Bumsuit: Manufacturing Innovative Baby Care Products with the Thought of Delivering the Highest Quality

Manish Gilada, Managing Director, Bumsuit

Manish Gilada

Managing Director, Bumsuit

The baby products market in India is expanding rapidly. Within this segment, the hygiene products segment is witnessing a remarkable increase in the number of brands popping up everyday. The demand for high-quality and comfortable products, particularly diapers and wipes, that do not give babies a rash or expose them to harmful chemicals is higher than ever. Parents today are much more conscious in making choices about baby care products. Additionally, there is growing strictness from regulatory authorities, which is driving the industry to advance towards higher quality products.

However, a major number of brands struggle to fulfill the regulatory requirements. Alternatively, many brands that capably meet these needs do so at the cost of increased end product prices. Given the Indian market’s price sensitivity, this becomes a significant challenge. Nevertheless, Kamson Healthcare, a Hyderabad-based baby care products manufacturing company balances price and quality to provide Indian babies with top-notch products that they deserve, irrespective of the parents’ economic backgrounds. A brand developed by Indians, Bumsuit is here to revolutionize the babycare industry in every aspect.

The Inception Saga

An extension of Kamson, Bumsuit is a baby hygiene products brand that manufactures diapers in two categories: premium and standard, with the only difference being the absorption time. While the premium range lasts for up to 12 hours, the standard range lasts for about 10 hours. With exceptional manufacturing facilities adhering to the class 100,000 hygiene level, the company stands out for manufacturing high-quality products in highly pristine conditions like those required for the manufacturing of pharma products. Kamson Hygiene Care is the only company in India with such manufacturing infrastructure, setting it a class-apart in the industry.

Our Vision Is Our Strength, We Identify Problems In Our Daily Life & Work For Better Solutions – That’s Nothing But R&D

Manish Gilada, Managing Director, Bumsuit

Leveraging its meticulous manufacturing capabilities, and a record of over 13 years for manufacturing high quality products (under the umbrella of Kamson Group which manufactures baby cosmetic products like shampoos, lotions, oils and more for Himalaya), the company stands as the only OEM for baby Diapers in Telangana.

“As Bumsuit, our vision is to deliver the best quality of products for babies across India. Anchored by this vision, we have introduced some revolutionary features in baby diapers. Wearing these diapers, babies are not only sure to be comfortable, they will also be protected, since our diapers come with a mosquito protection. Envisioned by fathers like me, our products come with unique features which address a number of parental concerns such as the quality, easy Front and Back identification, absorption capability, impact on the baby’s skin, and more”, shares Manish Gilada, Managing Director, Bumsuit.

The company’s USP stems from its vision, which is to give babies a product which they can stay comfortable and happy in. As such, the firm has dedicated its capabilities to manufacturing a premium grade of products which is slightly more expensive and a standard grade of products, which is more economical, without any significant difference between the two categories.

“We are driven by a simple belief. Whether a baby is born in a high-income home, or a lower-income home, they should not suffer. While those with greater disposable incomes can afford a more expensive product, those with restricted means, cannot spend so much on a commodity like diapers. However, children should net bear the brunt of such things. For us, children are all the same, and deserve the same amenities and comfort. This is why we make diapers in the same quality across our categories, ensuring every child is equally protected”, further adds Manish.

Apart from this, the company has also introduced an innovative mosquito protection feature, and a 3D leak guard to all the diapers, making sure leakage is not an issue. But that’s not where it stops. Bumsuit has also introduced a bubble layer technology on the surface that comes in contact with the baby’s body, ensuring a soft and comfortable wearing experience. Additionally, a very unique feature is the mascot which is printed on all diapers. The mascot’s face is printed towards the front portion, and its tail on the back, making it simple to identify the front and the back of the diaper.

Trusted Quality Manufacturing

When it comes to quality, Bumsuit believes in taking comprehensive measures to ensure every baby that wears a Bumsuit diaper is comfortable at all times, and parents are at peace, knowing their babies are safe. The quality assurance measures start from selecting the leading raw material vendors from across the globe. The firm makes it a point to choose vendors that follow the same quality parameters as it does. The firm imports pulp, which along with sap is the key ingredient in making diapers from Canada and Korea, the glue which needs to be strong and safe from another international MNC, and the plastic from yet another major international vendor.

“When it comes to quality, finding the appropriate vendors for raw materials is a non-negotiable practice for us. Additionally, when it comes to manufacturing, we adhere to pharma sector grade of manufacturing practices, which means that our antimicrobial products are made in a facility where even the air is free from microbial contamination. Our facilities are completely automated, and temperature controlled, so there is no interaction of our products with any kinds of contaminants

like dirt, sweat, or anything else”, further adds Manish.

In addition to ensuring manufacturing cleanliness, the company also conducts tests on manufactured products in a dedicated lab, making sure that every batch of products meets the high Bumsuit standards aligned with regulatory approved norms. Moreover, the company continually strives to upgrade quality, to ensure it becomes the best product company for babies.

Journey & Future Roadmap

With a highly equipped and advanced manufacturing facility, and a brilliant R&D team, that helps the company navigate various innovative ideas for product improvement and invention, Bumsuit has traversed a very interesting journey thus far. In fact, as a result of its unique diaper innovations, the company has rapidly expanded across India in a mere seven months since establishment. Today, Bumsuit is present in large retail stores and other shopping channels, and has received tremendous visibility and feedback from the market.

“Our achievements are the result of the collective efforts of our diverse and vibrant teams. A key role is played by our marketing team’s unique vision which is evident in our packaging. Our premium range is in orange color, the standard range in green. We are also developing a new product whose packaging will be blue and white, all together, these would make up the colors of the flag, signifying our dedication as an Indian brand, for the domestic consumer”, lastly shares Manish.

Propelled by its vision to transform the baby products sector by developing diverse products that tackle specific challenges, Bumsuit has ambitious plans for the future, such as introducing a unique new product that can cool down the baby’s body temperature and keep them comfortable. In addition to this, the firm has multiple more new products in the pipeline which all aim to provide greater joy to children. With this baby-focused approach, Bumsuit is poised to rapidly become a market leader in this sector.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.